We are live on ! Find out more
JY

Jeff Yass Susquehanna International Group

AUM $1.28T
1-Year Est. Return 58.89%
 

Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.

This Fund
S&P 500
This Quarter Est. Return
-3.2%
1 Year Est. Return
+58.89%
3 Year Est. Return
+161.44%
5 Year Est. Return
+153.95%
10 Year Est. Return
+545.54%
AUM
$745B
AUM Growth
+$33.9B
Cap. Flow
+$45.4B
Cap. Flow %
6.09%
Top 10 Hldgs %
31.69%
Holding
14,193
New
1,741
Increased
5,205
Reduced
5,319
Closed
1,559

Top Sells

Rank Stock Value
1
DIS icon
Walt Disney
DIS
+$2.17B
2
AMZN icon
Amazon
AMZN
+$1.98B
3
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$1.79B
4
NVDA icon
NVIDIA
NVDA
+$1.18B
5
WFC icon
Wells Fargo
WFC
+$827M

Sector Composition

Rank Sector Weight
1 Technology 1.89%
2 Consumer Discretionary 1.29%
3 Communication Services 0.93%
4 Healthcare 0.89%
5 Financials 0.8%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DRH icon
12026
PUT
Diamondrock Hospitality Co
DRH
$2.58B
$95K ﹤0.01%
+10,000
New +$89.4K
MREO
12027
CALL
Mereo BioPharma
MREO
$44.4M
$95K ﹤0.01%
39,100
-31,500
-45% -$83.4K
OVID icon
12028
PUT
Ovid Therapeutics
OVID
$562M
$95K ﹤0.01%
28,300
+5,900
+26% +$21.5K
PBT
12029
CALL
Permian Basin Royalty Trust
PBT
$1.57B
$95K ﹤0.01%
+16,500
New +$87.5K
PMCB icon
12030
CALL
PharmaCyte Biotech
PMCB
$5.8M
$95K ﹤0.01%
+30,100
New +$106K
RCOR
12031
DELISTED
Renovacor, Inc.
RCOR
$95K ﹤0.01%
+10,521
New +$103K
LFVN icon
12032
LifeVantage
LFVN
$83.4M
$94K ﹤0.01%
13,918
+2,114
+18% +$15.5K
OPTN
12033
DELISTED
OptiNose
OPTN
$94K ﹤0.01%
2,096
-439
-17% -$18.4K
WKEY
12034
CALL
WISeKey
WKEY
$76.4M
$94K ﹤0.01%
3,020
-8,680
-74% -$302K
QNTM
12035
CALL
Quantum Biopharma Class B Subordinate Voting Shares
QNTM
$129
$94K ﹤0.01%
918
-734
-44% -$78.4K
MREO
12036
Mereo BioPharma
MREO
$44.4M
$93K ﹤0.01%
38,582
+17,453
+83% +$46.2K
CCO icon
12037
CALL
Clear Channel Outdoor Holdings
CCO
$1.22B
$92K ﹤0.01%
33,800
-94,100
-74% -$235K
KRBP
12038
PUT
DELISTED
Kiromic BioPharma, Inc. Common Stock
KRBP
$92K ﹤0.01%
+1,003
New +$104K
MEUSW
12039
DELISTED
23andMe Holding Co Warrant
MEUSW
$92K ﹤0.01%
50,000
CPSS icon
12040
PUT
Consumer Portfolio Services
CPSS
$204M
$91K ﹤0.01%
15,600
+4,000
+34% +$21.1K
GIFI
12041
DELISTED
Gulf Island Fabrication
GIFI
$91K ﹤0.01%
22,933
-4,934
-18% -$21.7K
SOGP
12042
PUT
Sound Group
SOGP
$56.2M
$91K ﹤0.01%
2,870
-10,580
-79% -$476K
SRT
12043
DELISTED
Startek Inc.
SRT
$91K ﹤0.01%
+16,493
New +$101K
EXTN
12044
CALL
DELISTED
Exterran Corporation
EXTN
$91K ﹤0.01%
+20,500
New +$86.9K
CLNN icon
12045
PUT
Clene
CLNN
$59.7M
$90K ﹤0.01%
+660
New +$113K
CNET icon
12046
ZW Data Action Technologies
CNET
$5.25M
$90K ﹤0.01%
3,638
+493
+16% +$14.9K
IMUX icon
12047
CALL
Immunic
IMUX
$225M
$90K ﹤0.01%
1,020
PUMP icon
12048
PUT
ProPetro Holding
PUMP
$1.31B
$90K ﹤0.01%
10,400
-267,700
-96% -$2.09M
RKDA icon
12049
CALL
Arcadia Biosciences
RKDA
$1.24M
$90K ﹤0.01%
1,089
-2,722
-71% -$255K
TRIB
12050
PUT
Trinity Biotech
TRIB
$7.8M
$90K ﹤0.01%
277
-456
-62% -$160K

Similar funds

Jeff Yass's Q3 2021 Portfolio in Review

As of Q3 2021, Jeff Yass held 14,193 positions worth $745B, up 4.8% from $712B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Jeff Yass deployed $45.4B of net new capital in Q3 2021, opening 1,741 new positions and adding to 5,205 existing holdings. Its largest new stake was InMode: 613,660 shares worth $48.9M.

By sector, the portfolio is most concentrated in Technology at 1.9% of assets, down from 1.9% a quarter earlier, followed by Consumer Discretionary and Communication Services.

On the sell side, the largest reduction was Walt Disney, an estimated $2.17B trimmed.

  • Jeff Yass's largest Q3 2021 buy was InMode: 613,660 shares worth $48.9M.
  • Jeff Yass added most to Zoom in Q3 2021, an estimated $834M increase.
  • Jeff Yass's biggest Q3 2021 reduction was Walt Disney, cutting an estimated $2.17B.
  • Jeff Yass fully exited PRA Health Sciences, Inc. in Q3 2021, selling an estimated $103M.
  • Jeff Yass's ten largest holdings make up 32% of its $745B portfolio in Q3 2021.
  • Jeff Yass opened 1,741 new positions and closed 1,559 in Q3 2021.
  • Jeff Yass's portfolio value rose 4.8% quarter-over-quarter to $745B.

Based on Susquehanna International Group's 13F filing for Q3 2021, filed 15 Nov 2021.